PBMC Humanized Tumor Models for Evaluating T-cell Engagers
T-cell engagers (TCEs) are a class of bispecific antibody-based immunotherapies designed to bring T cells into close proximity with cancer cells, triggering the immune system to kill the cancer cells. TCEs bind to the CD3 complex on T cells and a tumor-specific antigen on cancer cells. The contact formed by the TCE creates an immunological synapse that mimics the natural immune interaction between a T-cell and a target cell.
PBMC-humanized tumor models are an effective tool for evaluating TCEs, as these models provide human T-cells (for engagement via CD3), human tumor antigens, and a functional immune-tumor interface that reflects aspects of the TCE mechanism. WuXi AppTec offers a broad panel of in-house PBMC humanized tumor models for studying multiple cancer types against validated targets.
PBMC Humanized Tumor Models for Evaluating T Cell Engagers
Related Content
Bispecific antibodies have emerged as an important modality in oncology, although their broader application can be limited by manufacturing complexity...
VIEW RESOURCEAs PD-1/PD-L1 x VEGF-targeted bispecific antibodies gain momentum in oncology, selecting the right preclinical models is becoming increasingly important. These...
VIEW RESOURCE